Amundi »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Amundi

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Amundi

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.3M 8.0M 0.91
2023-09-30 $7.3M 8.0M 0.91

More positions owned by Amundi

Apple (AAPL)
Amazon Commstck (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)
Advanced Micro Devices Commstck (AMD)
Stellantis SHS (STLA)
Home Depot (HD)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Mastercard Cl A (MA)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)

View all positions for Amundi

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1